<SEC-DOCUMENT>0001104659-21-000308-index.html : 20210104
<SEC-HEADER>0001104659-21-000308.hdr.sgml : 20210104
<ACCEPTANCE-DATETIME>20210104161046
ACCESSION NUMBER:		0001104659-21-000308
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20201230
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210104
DATE AS OF CHANGE:		20210104

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ENZON PHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0000727510
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				222372868
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36435
		FILM NUMBER:		21501878

	BUSINESS ADDRESS:	
		STREET 1:		20 COMMERCE DRIVE, SUITE 135
		CITY:			CRANFORD
		STATE:			NJ
		ZIP:			07016
		BUSINESS PHONE:		732-980-4500

	MAIL ADDRESS:	
		STREET 1:		20 COMMERCE DRIVE, SUITE 135
		CITY:			CRANFORD
		STATE:			NJ
		ZIP:			07016

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ENZON PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	20060324

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ENZON PHARMACEUTICALS  INC
		DATE OF NAME CHANGE:	20021211

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ENZON PHARMACEUTICAL  INC
		DATE OF NAME CHANGE:	20021210
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm211484d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
Document 1 - file: tm211484d1_8k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tm211484d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
Document 2 - file: tm211484d1_ex99-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: image_001.jpg

</DOCUMENT>
</SEC-DOCUMENT>